Product Recalls in Wisconsin

Product recalls affecting Wisconsin — including food, drugs, consumer products, medical devices, and vehicles distributed to Wisconsin. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,692 recalls have been distributed to Wisconsin in the last 12 months.

52,482 total recalls
2,692 in last 12 months

Showing 92819300 of 13,395 recalls

DrugNovember 4, 2015· Pine Pharmaceuticals, LLC

Recalled Item: Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal...

The Issue: Presence of particulate matter: Presence of silicone oil microdroplets in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 4, 2015· Dr. Reddy's Laboratories, Inc.

Recalled Item: Paricalcitol Capsules Recalled by Dr. Reddy's Laboratories, Inc. Due to...

The Issue: Failed Tablet/Capsule Specifications: Product recalled due to reports of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 4, 2015· Dr. Reddy's Laboratories, Inc.

Recalled Item: Paricalcitol Capsules Recalled by Dr. Reddy's Laboratories, Inc. Due to...

The Issue: Failed Tablet/Capsule Specifications: Product recalled due to reports of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 4, 2015· Pine Pharmaceuticals, LLC

Recalled Item: Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 Recalled by Pine...

The Issue: Presence of particulate matter: Presence of silicone oil microdroplets in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 4, 2015· Pine Pharmaceuticals, LLC

Recalled Item: Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Recalled by Pine...

The Issue: Presence of particulate matter: Presence of silicone oil microdroplets in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 4, 2015· Pine Pharmaceuticals, LLC

Recalled Item: Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Recalled by Pine...

The Issue: Presence of particulate matter: Presence of silicone oil microdroplets in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 2, 2015· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Meclizine Hydrochloride Tablets Recalled by Mylan Institutional, Inc....

The Issue: Failed Impurities/Degradation Specifications: Out of specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 29, 2015· Amerisource Health Services

Recalled Item: HYDROCHLOROTHIAZIDE CAPSULES Recalled by Amerisource Health Services Due to...

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 28, 2015· Sanofi-Aventis U.S. LLC

Recalled Item: Auvi-Q (epinephrine injection Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: Defective Delivery System; potential to have inaccurate dosage delivery

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 28, 2015· Sanofi-Aventis U.S. LLC

Recalled Item: Auvi-Q (epinephrine injection Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: Defective Delivery System; potential to have inaccurate dosage delivery

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 27, 2015· Geritrex Corp

Recalled Item: Carbo-O-Philic 40 Cream 40% (Urea) tubes Recalled by Geritrex Corp Due to...

The Issue: Marketed without an Approved NDA/ANDA: FDA has determined that the products...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 27, 2015· Geritrex Corp

Recalled Item: Carbo-O-Philic 40 Gel 40% (Urea) NET WT tube Recalled by Geritrex Corp Due...

The Issue: Marketed without an Approved NDA/ANDA: FDA has determined that the products...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 27, 2015· Geritrex Corp

Recalled Item: GRx HiCort 25 (hydrocortisone acetate 25 mg) Suppositories Recalled by...

The Issue: Marketed without an Approved NDA/ANDA: FDA has determined that the products...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 27, 2015· Geritrex Corp

Recalled Item: Polyethylene Glycol 3350-GRX Powder 100% jars a) 8.4 oz (250 Recalled by...

The Issue: Marketed without an Approved NDA/ANDA: FDA has determined that the products...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 26, 2015· Par Pharmaceutical Inc.

Recalled Item: Meclizine Hydrochloride Tablets USP Recalled by Par Pharmaceutical Inc. Due...

The Issue: Failed Impurities/Degradation Specifications: Out of specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 26, 2015· Par Pharmaceutical Inc.

Recalled Item: Meclizine Hydrochloride Tablets Recalled by Par Pharmaceutical Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications: Out of specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 21, 2015· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: Presence of Foreign Tablets/Capsules: one foreign capsule identified as...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 21, 2015· Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals

Recalled Item: RANITIDINE SYRUP (RANITIDINE ORAL SOLUTION Recalled by Vintage...

The Issue: Failed Stability Specifications: Out of Specification results obtained for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 20, 2015· Teva Pharmaceutical Industries

Recalled Item: Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg Recalled by...

The Issue: Labeling: Incorrect or Missing Lot AND/OR Exp Date.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 19, 2015· Western Drug

Recalled Item: Testosterone CYP Inj 200 mg/mL Recalled by Western Drug Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund